Ra capital administration sells $3.8 million in AN2 therapeutics inventory By Investing.com
Traders following the actions of RA Capital Administration, L.P. may be aware…
Akero Therapeutics COO sells shares value over $130k By Investing.com
Jonathan Younger, the Chief Working Officer of Akero Therapeutics, Inc. (NASDAQ:), has…
Halozyme Therapeutics hits 52-week excessive, reaching $56.66 By Investing.com
Halozyme (NASDAQ:) Therapeutics, Inc. (HALO) has reached a brand new 52-week excessive,…
Scotiabank sees ‘deep worth’ in Sage Therapeutics inventory regardless of research setback By Investing.com
On Wednesday, Scotiabank adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE), decreasing the…
Centrexion Therapeutics Corp hits 52-week excessive, reaching 2.285 USD By Investing.com
Centrexion Therapeutics Corp (CNTX) has reached a brand new 52-week excessive, with…
Mineralys Therapeutics CMO sells $7,875 in inventory, buys shares at $1.08 By Investing.com
In a current transaction, Chief Medical Officer David Malcom Rodman of Mineralys…
Enliven Therapeutics COO sells over $1.25m in firm inventory By Investing.com
In a current transaction, Anish Patel, the Chief Working Officer (COO) of…
